Core Viewpoint - Gladstone Investment (GAIN) is anticipated to report a year-over-year decline in earnings despite an increase in revenues for the quarter ending March 2025, with the consensus outlook indicating a potential impact on its near-term stock price [1][2]. Earnings Expectations - The upcoming earnings report is expected to reveal quarterly earnings of $0.23 per share, reflecting a year-over-year decrease of 4.2%, while revenues are projected to be $24.78 million, an increase of 4.8% from the previous year [3]. - The consensus EPS estimate has been revised down by 1.43% over the last 30 days, indicating a bearish sentiment among analysts regarding the company's earnings prospects [4][10]. Earnings Surprise Prediction - The Zacks Earnings ESP model shows a negative Earnings ESP of -1.43%, suggesting that the Most Accurate Estimate is lower than the Zacks Consensus Estimate, complicating predictions of an earnings beat [11][10]. - The company currently holds a Zacks Rank of 3 (Hold), which further indicates uncertainty regarding the likelihood of surpassing the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Gladstone Investment was expected to post earnings of $0.24 per share but delivered only $0.23, resulting in a surprise of -4.17% [12]. - The company has not exceeded consensus EPS estimates in any of the last four quarters, highlighting a trend of underperformance [13]. Industry Comparison - In comparison, Morgan Stanley Direct Lending Fund (MSDL), another player in the Zacks Financial - SBIC & Commercial Industry, is expected to report earnings of $0.56 per share for the same quarter, reflecting a year-over-year decline of 11.1%, with revenues anticipated at $103.52 million, up 4.5% [17]. - Similar to Gladstone Investment, Morgan Stanley Direct Lending Fund has a negative Earnings ESP of -3.57% and a Zacks Rank of 3, making it difficult to predict an earnings beat [18].

The market expects 908 Devices Inc. (MASS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 13, 2025, might help the stock move higher if these key numbers ar ...

Company Overview - Ovid Therapeutics (OVID) is expected to report a quarterly loss of $0.14 per share, reflecting a year-over-year change of +17.7% [3] - Revenues are anticipated to be $0.07 million, down 53.3% from the same quarter last year [3] Earnings Expectations - The consensus EPS estimate has remained unchanged over the last 30 days, indicating a stable outlook from covering analysts [4] - The Most Accurate Estimate for Ovid is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -1.45%, suggesting a bearish sentiment among analysts [10] Historical Performance - In the last reported quarter, Ovid was expected to post a loss of $0.16 per share but actually reported a loss of $0.13, achieving a surprise of +18.75% [12] - Over the past four quarters, Ovid has beaten consensus EPS estimates three times [13] Comparative Industry Analysis - ImmunityBio (IBRX), another player in the Zacks Medical - Biomedical and Genetics industry, is expected to report earnings per share of $0.12 for the same quarter, indicating a year-over-year change of +40% [17] - ImmunityBio's revenues are projected to be $15.69 million, up 39125% from the previous year [17] - The consensus EPS estimate for ImmunityBio has been revised 1.5% lower over the last 30 days, resulting in an Earnings ESP of -2.85% [18]

Core Viewpoint - The market anticipates On Holding (ONON) to report a year-over-year decline in earnings despite an increase in revenues when it releases its quarterly results for the period ending March 2025 [1][2]. Earnings Expectations - On Holding is expected to report earnings of $0.24 per share, reflecting a year-over-year decrease of 36.8% [3]. - Revenue projections stand at $773.88 million, which represents a 33.1% increase compared to the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 0.94% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for On Holding is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +4.17% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive Earnings ESP reading is a strong indicator of an earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - On Holding currently holds a Zacks Rank of 3, indicating a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, On Holding exceeded the expected earnings of $0.20 per share by delivering $0.38, resulting in a surprise of +90% [12]. - Over the past four quarters, On Holding has beaten consensus EPS estimates two times [13]. Industry Context - In the Zacks Retail - Apparel and Shoes industry, Tapestry (TPR) is expected to report earnings of $0.89 per share for the same quarter, reflecting a year-over-year increase of 9.9% [17]. - Tapestry's revenue is projected to be $1.53 billion, up 3.1% from the previous year [17].

Company Overview - Vivos Therapeutics, Inc. (VVOS) is expected to report a quarterly loss of $0.44 per share, reflecting a year-over-year change of +73% [3] - Revenues are anticipated to be $3.7 million, which is an increase of 8.2% from the same quarter last year [3] Earnings Estimates and Revisions - The consensus EPS estimate has been revised 14.71% lower in the last 30 days, indicating a reassessment by analysts [4] - The Most Accurate Estimate for Vivos is the same as the Zacks Consensus Estimate, resulting in an Earnings ESP of 0% [10][11] Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, but its predictive power is significant mainly for positive readings [7] - Vivos currently holds a Zacks Rank of 4, making it challenging to predict an earnings beat [11] Historical Performance - In the last reported quarter, Vivos was expected to post a loss of $0.43 per share but actually reported a loss of $0.28, resulting in a surprise of +34.88% [12] - Over the past four quarters, Vivos has beaten consensus EPS estimates two times [13] Industry Comparison - Ironwood Pharmaceuticals (IRWD), another player in the Zacks Medical - Drugs industry, is expected to report a loss of $0.05 per share, indicating a year-over-year change of -150% [17] - Ironwood's revenues are projected to be $59.45 million, down 20.6% from the previous year [17] - The consensus EPS estimate for Ironwood has been revised 28.6% lower in the last 30 days, with an Earnings ESP of -121.05% [18]

Core Insights - Avient reported revenue of $826.6 million for the quarter ended March 2025, a decrease of 0.3% year-over-year, with EPS remaining unchanged at $0.76 [1] - The revenue fell short of the Zacks Consensus Estimate of $833.46 million, resulting in a surprise of -0.82%, while the EPS exceeded the consensus estimate of $0.75 by 1.33% [1] Financial Performance Metrics - Specialty Engineered Materials sales were $308.40 million, below the average estimate of $312.56 million, reflecting a year-over-year decline of 1.9% [4] - Color, Additives and Inks sales reached $519.70 million, slightly below the average estimate of $521.10 million, with a year-over-year increase of 0.9% [4] - Corporate sales reported a loss of -$1.50 million, worse than the average estimate of -$0.80 million, marking a significant year-over-year change of +114.3% [4] Operating Income Analysis - Operating income for Color, Additives and Inks was $78.60 million, slightly above the average estimate of $78.01 million [4] - Operating income for Specialty Engineered Materials was $47.10 million, below the average estimate of $49.71 million [4] - Corporate operating loss was -$125 million, significantly worse than the average estimate of -$32.27 million [4] Stock Performance - Avient's shares have returned +13.9% over the past month, outperforming the Zacks S&P 500 composite's +11.5% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market in the near term [3]

Cheniere Energy, Inc. (LNG) is set to release first-quarter results on May 8. The Zacks Consensus Estimate for earnings is $2.81 per share on revenues of $4.5 billion. Let's delve into the factors that are likely to have influenced the liquefied natural gas (LNG) exporter's performance in the March quarter. But it's worth taking a look at Cheniere Energy's previous-quarter performance first. Highlights of Q4 Earnings & Surprise History In the last reported quarter, this Houston, TX-based transporter of supe ...

Core Viewpoint - WEC Energy Group reported quarterly earnings of $2.27 per share, exceeding the Zacks Consensus Estimate of $2.19 per share, and showing an increase from $1.97 per share a year ago, indicating a positive earnings surprise of 3.65% [1] Financial Performance - The company achieved revenues of $3.15 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 11.85%, compared to $2.68 billion in the same quarter last year [2] - Over the last four quarters, WEC Energy has exceeded consensus EPS estimates three times [2] Stock Performance - WEC Energy shares have increased approximately 15.6% since the beginning of the year, contrasting with a decline of 3.9% in the S&P 500 [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating expectations of outperforming the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.75 on revenues of $1.87 billion, and for the current fiscal year, it is $5.24 on revenues of $9.34 billion [7] - The trend of estimate revisions for WEC Energy is favorable, which could influence future stock movements [6] Industry Context - The Utility - Electric Power industry, to which WEC Energy belongs, is currently ranked in the top 20% of over 250 Zacks industries, suggesting a strong performance potential [8]

Core Viewpoint - Gartner reported quarterly earnings of $2.98 per share, exceeding the Zacks Consensus Estimate of $2.72 per share, and showing a year-over-year increase from $2.93 per share [1] - The company has consistently surpassed consensus EPS estimates over the last four quarters [2] Financial Performance - Gartner's revenues for the quarter ended March 2025 were $1.53 billion, matching the Zacks Consensus Estimate and reflecting a year-over-year increase from $1.47 billion [2] - The company has also exceeded consensus revenue estimates in the last four quarters [2] Stock Performance and Outlook - Gartner shares have declined approximately 11.9% since the beginning of the year, compared to a 3.9% decline in the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $3.28, with expected revenues of $1.66 billion, and for the current fiscal year, the estimate is $12.18 on revenues of $6.51 billion [7] Industry Context - The Consulting Services industry, to which Gartner belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact Gartner's stock performance [5]

Core Insights - Duke Energy reported quarterly earnings of $1.76 per share, exceeding the Zacks Consensus Estimate of $1.59 per share, and up from $1.44 per share a year ago, representing an earnings surprise of 10.69% [1] - The company generated revenues of $8.25 billion for the quarter, surpassing the Zacks Consensus Estimate by 2.33%, and an increase from $7.67 billion year-over-year [2] - Duke Energy shares have increased by approximately 12.1% since the beginning of the year, contrasting with a -3.9% decline in the S&P 500 [3] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $1.26 on revenues of $7.35 billion, and for the current fiscal year, it is $6.32 on revenues of $31.81 billion [7] - The estimate revisions trend for Duke Energy is currently unfavorable, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Utility - Electric Power industry, to which Duke Energy belongs, is currently ranked in the top 20% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]